Key Market Indicators
**Mauritian Vaccination Coverage to Remain Steady at 97% by 2028** Mauritius is projected to maintain its vaccination coverage for children aged one year at 97% by 2028, showing no change from the current rate in 2023. This statistic has remained stable since 1985, with the market experiencing a slight annual decline of 0.2 percentage points. **Vaccine Imports to Surge to $7.3 Million** Mauritius is expected to see a significant increase in vaccine imports, reaching approximately $7.3 million by 2028, up from nearly $6 million in 2023. This marks an average annual growth rate of 3%. The demand for vaccines in Mauritius has been rising steadily, with a yearly growth rate of 3.6% since 1998. **Vaccine Exports to Grow by Nearly 30%** On the export front, Mauritius anticipates its vaccine exports to climb to around $220,000 by 2028, from $173,000 in 2023. This translates to an average annual growth rate of 3.7%. Since 2007, the country's vaccine supply has grown at a rate of 1.6% per year. In 2023, Mauritius ranked 48th in vaccine exports, with Argentina slightly ahead at the same value. Leading the rankings were Belgium, the United Kingdom, and France, occupying the second, third, and fourth spots, respectively. **Vaccination Coverage to Maintain Stability at 98%** Similarly, the vaccination coverage for another segment of children aged one year in Mauritius is also set to remain stable at 98% by 2028, unchanged from 2023. This stability reflects a consistent trend in the Mauritian market since 1985.
